Octagon Capital Advisors LP

Position in AVBP — ArriVent BioPharma, Inc.

CIK 1839435 NEW YORK, NY

Position in AVBP

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$45,472,215

+$5,814,609 QoQ

Shares Held

1,971,054

0.0% QoQ

Ownership

4.23%

of shares outstanding

% of Portfolio

5.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Octagon Capital Advisors LP holds $869,736,107 across 27 Biotechnology names. AVBP ranks #6 (5.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DNTH	Dianthus Therapeutics, Inc. /DE/	1,946,667	$163,364,294
2	COGT	Cogent Biosciences, Inc.	2,350,000	$90,451,500
3	ABVX	Abivax S.A.	677,000	$75,383,950
4	ALMS	Alumis Inc.	2,830,700	$62,360,321
5	DFTX	Definium Therapeutics, Inc.	2,440,000	$46,116,000
6	AVBP	ArriVent BioPharma, Inc. This page	1,971,054	$45,472,215
7	TSHA	Taysha Gene Therapies, Inc.	8,859,911	$39,603,802
8	KYMR	Kymera Therapeutics, Inc.	425,000	$35,398,250

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$45,472,215	1,971,054	0.0%	Shares	Sole	2026-05-15
2025-12-31	$39,657,606	1,971,054	0.0%	Shares	Sole	2026-02-17
2025-09-30	$36,365,946	1,971,054	+1.3%	Shares	Sole	2025-11-14
2025-06-30	$42,365,595	1,946,054	-5.5%	Shares	Sole	2025-08-14
2025-03-31	$38,078,065	2,059,387	0.0%	Shares	Sole	2025-05-16
2024-12-31	$54,862,069	2,059,387	+4.2%	Shares	Sole	2025-02-14
2024-09-30	$46,445,094	1,976,387	+9.6%	Shares	Sole	2024-11-14
2024-06-30	$33,451,289	1,803,304	-7.2%	Shares	Sole	2024-08-14
2024-03-31	$34,716,910	1,943,836	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.